Cargando…
Screening for pulmonary arterial hypertension in systemic sclerosis
Pulmonary arterial hypertension (PAH) is a dreaded complication of systemic sclerosis (SSc) that occurs in ∼10% of patients. Most individuals present with severe symptoms, significant functional impairment and severe haemodynamics at diagnosis, and survival after PAH diagnosis is poor. Therefore, ea...
Autores principales: | Weatherald, Jason, Montani, David, Jevnikar, Mitja, Jaïs, Xavier, Savale, Laurent, Humbert, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488700/ https://www.ncbi.nlm.nih.gov/pubmed/31366460 http://dx.doi.org/10.1183/16000617.0023-2019 |
Ejemplares similares
-
Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce de Résistance?
por: Weatherald, Jason, et al.
Publicado: (2021) -
Acute decompensated pulmonary hypertension
por: Savale, Laurent, et al.
Publicado: (2017) -
Factors predicting outcome after pulmonary endarterectomy
por: Tromeur, Cécile, et al.
Publicado: (2018) -
Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis
por: Launay, David, et al.
Publicado: (2018) -
Reply to Jin et al. and to Sun et al.
por: Boucly, Athénaïs, et al.
Publicado: (2021)